| Authors |
|
| Abstract |
This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.
|
| Keywords | No keywords specified (fix it) |
| Categories | (categorize this paper) |
| Options |
Mark as duplicate
Export citation
Request removal from index
|
Download options
PhilArchive copy
Upload a copy of this paper Check publisher's policy Papers currently archived: 57,156
External links
(no proxy) Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library
- Only published works are available at libraries.
References found in this work BETA
No references found.
Citations of this work BETA
Ensuring the Quality, Fairness, and Integrity of Journal Peer Review: A Possible Role of Editors.David B. Resnik & Susan A. Elmore - 2016 - Science and Engineering Ethics 22 (1):169-188.
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW]Joel Lexchin - 2012 - Science and Engineering Ethics 18 (2):247-261.
Addressing Problems in Profit-Driven Research: How Can Feminist Conceptions of Objectivity Help?Kristen Intemann & Inmaculada de Melo-Martín - 2014 - European Journal for Philosophy of Science 4 (2):135-151.
Institutional Conflicts of Interest in Academic Research.David B. Resnik - 2015 - Science and Engineering Ethics 25 (6):1661-1669.
Financial Conflicts of Interest and Criteria for Research Credibility.Kevin C. Elliott - 2014 - Erkenntnis 79 (S5):917-937.
View all 13 citations / Add more citations
Similar books and articles
Researcher Views About Funding Sources and Conflicts of Interest in Nanotechnology.Katherine A. McComas - 2012 - Science and Engineering Ethics 18 (4):699-717.
Ghost Management: How Much of the Medical Literature is Shaped Behind the Scenes by the Pharmaceutical Industry?Sergio Sismondo - manuscript
Commercialism and Universities: An Ethical Analysis. [REVIEW]Richard Carter - 2010 - Journal of Academic Ethics 8 (1):1-19.
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW]Joel Lexchin - 2012 - Science and Engineering Ethics 18 (2):247-261.
Understanding Physician-Pharmaceutical Industry Interactions.Shaili Jain - 2007 - Cambridge University Press.
Pharmaceutical Company Gifts: From Voluntary Standards to Legal Demands.Rebecca Dresser - 2006 - Hastings Center Report 36 (3):8-9.
Conflicts of Interest in Drug Development: The Practices of Merck & Co., Inc.Laurence J. Hirsch - 2002 - Science and Engineering Ethics 8 (3):429-442.
Analytics
Added to PP index
2009-01-28
Total views
35 ( #292,826 of 2,411,732 )
Recent downloads (6 months)
1 ( #539,061 of 2,411,732 )
2009-01-28
Total views
35 ( #292,826 of 2,411,732 )
Recent downloads (6 months)
1 ( #539,061 of 2,411,732 )
How can I increase my downloads?
Downloads
